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Abstract 
By 2024, there will be an estimated 18.9 million cancer survivors in the United States. 
Cancer survivorship is defined as the time period from cancer diagnosis through the remainder of 
life. Quality of life (QOL) is important to cancer survivors because they may have many side 
effects from their cancer and treatment that could decrease their satisfaction in their daily lives. 
Mind body movement exercise (MBME) such as yoga, Tai Chi, and Qigong, is a complementary 
health approach that can be vital in improving the overall health of cancer survivors. Smoking 
cessation may also increase cancer survivors’ QOL and efficacy of treatment by decreasing 
mortality, treatment toxicity, infection, and risk for a second primary cancer. The purpose of this 
study was to describe QOL scores among cancer survivors who participated in MBME classes. 
This was a one group repeated measures design with cancer survivors who were enrolled in a 10 
week MBME class.  Data collection occurred at the time of enrollment and at 6 months after 
study completion. Participants were recruited from The James Cancer Hospital’s James Care for 
Life MBME classes. QOL was measured with the FACT-G. There were 33 participants at 
baseline and 24 at 6 months; 8 with a smoking history for both time points.  Patients without a 
smoking history had a mean (SD) FACT-G score of 77.41 (17.76) at baseline and 82.89 (20.97) 
at 6 months. Patients with a smoking history had a mean (SD) FACT-G score of 75.31 (15.95) at 
baseline and of 80.62(15.45) at 6 months. QOL scores for participants with a smoking history 
were slightly lower than those who were never smokers at both time points. This reinforces the 
importance of smoking cessation at every stage in cancer survivorship. Future research on the 
benefits of MBME with a smoking cessation intervention among cancer survivors is warranted.   
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Chapter I: Statement of the Problem 
 
Introduction 
By 2024, there will be an estimated 18.9 million cancer survivors in the United States; an 
increase from 14.5 million survivors in 2014 (American Cancer Society, 2014). This increase in 
cancer survivors is due to multiple factors (Siegel, DeSantis, Virgo et al., 2012). For example, 
the effectiveness of chemotherapy has improved. Life expectancy in the United States has 
increased to 78.8 years in 2013 from 70.8 years in 1970 (CDC, 2015). The risk of cancer 
increases throughout life until old age (Ukraintseva & Yashin, 2003).  Since the population is 
living longer, they have a greater chance of developing cancer. The screening tools for cancer 
have become more reliable and sensitive, allowing cancer to be diagnosed earlier and treated 
earlier.  
Cancer survivorship is defined as the time period from diagnosis through the remainder 
of life. It can be described as having three phases: living with cancer, living through cancer, and 
living beyond cancer (NCI, n.d.). Living with cancer is the period of time surrounding diagnosis 
and treatment. Living through cancer is the time following treatment when the risk of 
reoccurring cancer is relatively strong. Living beyond cancer refers to the long term effects of 
cancer diagnosis and treatment. It is important to cancer survivors to have a high quality of life 
(QOL). Smoking cessation may also increase cancer survivors’ QOL and efficacy of treatment 
by decreasing mortality, treatment toxicity, infection, and risk for a second primary cancer 
(Gritz, Toll, Warren, 2014).  
Mind Body Movement Exercise (MBME) is a term used to describe therapeutic 
exercises, such as yoga, Tai Chi and Qigong and are considered complementary health 
approaches vital to the survivorship care plan (Mustian, Sprod, Janelsins, et al., 2013; Sprod, 
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Fernandez, Janelsins et al., 2015). MBME is a technique that has been used to improve physical 
and emotional health (Mustain et al., 2013; Sprod et al., 2015). Mind body movement decreases 
pain, stress, insomnia, and depression and increases coordination and gait speed. These 
interventions have been found to be beneficial for cancer survivors.  
 Yoga is a common stress reducing exercise and is known to reduce cancer-related fatigue 
as well as reduce pain (Sprod et al., 2015). Tai Chi, a form of martial arts and exercise, is known 
for slow, methodical movements with breathing and imagery with significant benefits to cancer 
patients (Wayne & Kaptchuk, 2008).  Qigong involves coordinated, gentle physical exercises 
and relaxation through meditation and breathing and has been shown to improve QOL in cancer 
patients  (Oh, Choi, Inamori, Rosenthal, & Yeung, 2013).  
Study Aims 
The purpose of this study was to investigate QOL among cancer survivors and to 
determine if smoking status as has an effect with cancer survivors’ QOL. The research objectives 
were to: 
1) Describe QOL scores among cancer survivors who participated in MBME classes. 
2) Describe QOL scores between participants with a smoking history to participants without 
a smoking history. 
 
Chapter II: Review of the Literature 
There are many aspects of a patient's life that changes when they are diagnosed with 
cancer.  Issues that cancer patients experience during survivorship include living with the lasting 
physical, emotional, spiritual, and financial consequences of a cancer diagnosis (CDC, 2014). 
Cancer survivors experience long term side effects of their disease and treatment. Due to these 
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side effects, survivors may worry about recurrence or developing a secondary cancer. Patients 
that are more likely to have fear of recurrence are younger in age, have poor coping skills, and 
have a poorer QOL than cancer survivors who did not have a fear of recurrence (Crist & 
Grunfeld, 2012).  
The patient may have lasting side effects from their treatments, such as weakness or 
being easily fatigued. Patients may experience depression or another mood disorder during this 
time. All of these experiences may cause patients to have a difficult time getting their life back to 
normal or establishing a new normal (NCI, n.d.). In addition, a cancer diagnosis can affect 
personal relationships. A cancer survivor’s family or friends may not know how to respond to the 
diagnosis and avoid the survivor, not want to talk about their illness, or change their behaviors 
towards the survivor (Wortman & Dunkel-Schetter, 1969). A patient may experience stronger 
spirituality or decreased spirituality in response to having cancer. Survivors may need counseling 
or funding to offset charges from their hospital stay and treatment. Economic hardship may also 
be something a patient experiences because of job loss of the survivor or caretaker, treatment 
costs, and treatment once the survivor is in remission. It is important to help the patient adjust to 
these changes so they can lead a healthy and productive life (CDC, 2014).  
Treatment Related Side Effects  
Survivors of cancer have many treatment and disease related side effects. Physical side 
effects can include pain, nausea, vomiting, diarrhea, constipation, anorexia, anemia, decreased 
immunity, lymphedema, and fatigue. Long term side effects can include: cataracts, infertility, 
skin changes, heart disease, lung disease, and increased risk of a secondary cancer (Mayo Clinic, 
2014). Psychosocial side effects can include anxiety, depression, and worry. Throughout 
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treatment, the patients will have many medical appointments and may take many additional 
medications. 
Fatigue 
 Many cancer survivors experience fatigue at some point during survivorship. Fatigue that 
is related to cancer is different than fatigue that is experienced by a non-cancer survivor. Cancer 
related fatigue is more severe, more distressing, and is less likely to be relieved with rest (REF). 
When cancer survivors experience fatigue, they are more likely to have problems sleeping, pain, 
and emotional issues (National Comprehensive Cancer Network, n.d.). Exercise and 
psychological interventions have been shown to be helpful in decreasing fatigue of cancer 
survivors (American Cancer Society, 2014). 
Tobacco Use 
Some cancer patients may wonder why they should stop smoking if they have received a 
diagnosis of cancer. Although the patient has already developed cancer, smoking cessation may 
increase their QOL and efficacy of treatment by decreasing mortality, toxicity, infection, and a 
risk for a second primary cancer (Gritz et al., 2014). Smoking cessation can also decrease pain 
levels. In a study by Daniel et al. (2009), lung cancer survivors who used tobacco were more 
likely to experience higher pain levels than patients that had quit smoking or had never smoked.   
 To increase the quality and duration of cancer survivorship, it is important that patients 
stop smoking. This can be a difficult task, and many patients may not have the resources to help 
them quit. Nicotine is a highly addictive component in cigarettes. When a patient uses a tobacco 
product, the nicotine activates a pathway in the brain when it binds to nicotinic receptors 
(Szamocki, 2013). When the nicotinic receptors are bound, dopamine is released. Dopamine is a 
neurotransmitter that is active in the reward pathway of the brain. When this pathway is 
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activated, a patient will experience feelings of pleasure. As the patient continues to use tobacco, 
they will have to use more tobacco every time to increase dopamine levels in their brain. If the 
patient does not use tobacco, they will begin to have withdrawal symptoms.  Symptoms of 
withdrawal include:  decreased heart rate, and increased caloric intake, craving for tobacco, 
confusion, depression and poor concentration (Hatsukami, Hughes, Pickens, & Svikis, 1984). 
 There are various medications that can be used to assist with smoking cessation. In order 
to reduce smoking craving and withdrawal symptoms, nicotine replacement therapy, bupropion, 
and varenicline can be used (Stead, Perera, Bullen et al., 2012). Nicotine replacement therapy 
stimulates the nicotinic receptors in the brain, just as using tobacco would (Molyneux, 2004).  
Varenicline works as an antagonist for the nicotinic receptors in the brain (Aubin, Luquiens, & 
Berlin, 2013).  
Quality of Life 
 QOL is important to cancer survivors. Although cancer is a physical disease, it has lasting 
effects on the entirety of the patient's life. It is important to not only diagnose and treat a patient 
that has cancer, but to also ensure that they will have a good QOL after their diagnosis.  QOL is a 
subjective measure that is based on a patient's perception of their life (Peplau, 1994). There are 
four aspects of QOL: physical, psychological, social, and spiritual (Ferrell, Hassey, & Grant, 
1995). In a randomized control trial, breast cancer patients were assigned to yoga and a yoga 
waiting list for 12 weeks. Patients who participated in yoga for 12 weeks had higher QOL scores 
than patients who were in the control group (Cohen, 2007). In patients with advanced gastric 
cancer, those who received chemotherapy had higher QOL scores than patients who only 
received supportive care (Thigpen, 1997). Breast cancer survivors who were diagnosed at an 
older age (>65) had a lower physical QOL score than survivors diagnosed when they were 
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younger than 65. Breast cancer survivors who were diagnosed at a younger age had a lower 
social QOL than those survivors who were older than 65. In colorectal cancer survivors, women 
were found to have more psychological and social QOL issues than men (Grant, Mcmullen, 
Altschuler et al., 2011).  In a randomized control trial with cancer patients, patients who did not 
have depression had a much higher QOL than patients who had depression (Brown, Kroenke, 
Theobald, Wu, & Tu, 2009). Cancer patients who continued to smoke after diagnosis had a lower 
QOL than cancer patients who quit smoking or did not have a smoking history (Hanna, 2004).  
Physical Changes to the body  
 There are many physical effects after cancer treatment. These changes may be from the 
treatment (e.g. surgery, chemotherapy, or radiation), from the cancer. Some common issues are: 
infertility issues, weight loss, sexual dysfunction, pain, learning problems, incontinence, 
endocrine changes, dental changes, and secondary cancers (MDAnderson, n.d.). Patients may 
have hair loss, scars, loss of a body part, and pain (Coping with Changes to your Body, 2012). 
Depression 
Patients may experience grief and sadness when they are diagnosed and throughout their 
treatment, this reaction is normal. Many patients do accept and adapt to their diagnosis of cancer. 
However, 25% of cancer patients will develop depression during their treatment (National 
Cancer Institute, 2014). Cancer patients develop depression around the same rates that patients 
with illnesses that make them similarly ill (Spiegel & Giese-Davis, 2003). For a patient to be 
diagnosed with depression, they must experience either a depressed mood or lack of interest in 
regular activities for at least two weeks. They must also exhibit at least four other depressive 
symptoms: fatigue, decreased appetite, problems sleeping, altered memory or concentration, 
suicidal ideation, and feelings of hopelessness, helplessness, guilt, and worthlessness.  Although 
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many of these symptoms can also be a result of cancer or treatment, depressive symptoms can 
extend further than what would just be from the cancer or treatment (Chochinov, 2001). There 
are many risk factors for developing depression for patients with cancer. History of depression, 
family history of depression, poorly controlled pain, history of drug or alcohol abuse, other 
medical conditions, and certain types of cancers increased the likelihood that the patient will 
develop depression (Chochinov, 2001). Depression in cancer patients is treated in a number of 
ways. Most often, the patients will receive a combination of therapies. Typically, patients are 
prescribed a medication and will also receive psychotherapy (Li, Fitzgerald, & Rodin, 2012).  
Social Support 
Patients may experience a change in social support and relationships due to a change in 
patient role (Cancer.net, 2014). A survivor who had previously been the primary caretaker for his 
family may have to take a less active role. The survivor's spouse may have to become the 
primary caretaker for the family, when they previously had not done so. Patients will have many 
follow up appointments to monitor their cancer status and to treat the side effects. This causes 
survivors to rely on others for transportation to appointments. All of these social changes can put 
stress on the survivor and his family.   
 
Chapter III: Methodology 
Design 
 This study is a one group repeated measures design. Participants were enrolled in a mind 
body movement class for 10 weeks.  Data collection occurred at the time of enrollment 
(baseline), 5 weeks, and 10 weeks and at 6 months after conclusion of the MBME class.  This 
paper will only report data from the baseline and 6-month data points. 
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Population Sample 
Participants for this study were recruited from The Ohio State University Wexner 
Medical Center-James Cancer Hospital's James Care for Life mind body movement classes (e.g. 
yoga, Tai Chi, Qigong). These classes were offered free of charge to cancer survivors and 
caregivers of cancer survivors. Cancer survivors did not need to participate in order for their 
caregiver to participate in any of the classes. Survivors and caregivers did not need to participate 
in the class at the same time. This paper will only report data from survivors. The class sessions 
lasted for 10 weeks and sessions were offered four times a year. Classes were offered in multiple 
locations throughout the Columbus metropolitan area, including iResolve fitness club (adjacent 
to downtown Columbus, Ohio), Stoneridge Medical Center (Dublin, Ohio), and the Stephanie 
Spielman Comprehensive Breast Center (Columbus, Ohio).  
Inclusion Criteria 
 Patients were 18 years or older, could read or speak English, had a diagnosis of cancer, 
provided informed consent, and were enrolled in yoga, Tai Chi, or Qigong.  
Data Collection Procedures 
 Potential participants were contacted before the first class of the session by the JCFL staff 
to inform them about the study and asked that they come early to the first session if they would 
like to participate. Survivors were also invited to participate prior to the first class of the session. 
Interested participants then provided informed consent before enrollment. Participants completed 
study questionnaires prior to class on the first class (i.e., baseline). At 6 months after program 
completion, participants were mailed a study questionnaire to complete and a $10 incentive card. 
Questionnaires for baseline and 6 months after program completion were identical.  
 
RUNNING HEAD: QOL AND SMOKING STATUS IN CANCER SURVIVORS 
 
11 
Data Collection Instruments 
 Measures that were collected in this study were: 1) socio-demographic; 2) health history 
(primary cancer, self-reported health status); 3) tobacco history; and 5) QOL (FACT-G).  Socio-
demographic data included age, gender, race and ethnic background, annual household income, 
education level, employment status. Health history included type of cancer primary, self-reported 
health status in general and self-reported health status now, compared to 1 year ago. Tobacco 
history included two categories:  never smoker and current or former smoker. QOL was 
measured by the Functional Assessment of Cancer Therapy-General (FACT-G) (Winstead-Fry & 
Schultz, 1997). 
   The FACT-G is a 27-item self-assessment tool that assesses QOL in patients with any 
type of cancer.  It has good reliability with an internal consistency score for the overall scale is 
0.89 (Winstead-Fry & Schultz, 1997). There are four categories of questions (i.e., physical, 
social/family, emotional, and functional well-being). There are 5 item responses ranging from 
“not at all” to “very much” (0-4). A higher score corresponds to a better QOL (Winstead-Fry & 
Schultz, 1977). There is an overall sum score with a range of 0-108.  Each category has a sum 
score; (e.g., 0-28 for the physical, social/family, and functional scales and 0-24 for the emotional 
scale).  
Data Analysis 
 All data was analyzed with means, standard deviations, and percentages. All data analysis 
was performed in SPSS. Descriptive statistics were calculated to describe the sample. All 
analyses were conducted in SPSS 23 (IBM).  
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Chapter IV: Results 
There were 33 participants who enrolled in the study at baseline and 24 participants at 6 
months.  Over half of the participants were women. The mean age of the participants was 60 
years old. The majority of the participants were Non-Hispanic white. Over half of the 
participants listed breast cancer as their primary cancer. Most participants were college educated 
and had a household income of over $50,000. The majority of participants described their health 
status as the same as or better than a year ago (See Table 1 for all Baseline Sample 
Characteristics). Eight participants had a smoking history; seven participants had smoked in the 
past and currently did not smoke and one participant currently smoked. Although health status 
between past smokers and current smoker is different, past smokers and current smokers’ health 
status is more similar than participants without any smoking history.  
 
Table 1:  Baseline Sample Characteristics (n=33) 
Variables N % Mean (SD) 
Age 32  60 (7.93) 
Gender 
Male 
Female 
 
5 
28 
 
15.2 
84.8 
 
Race/Ethnicity 
Non-Hispanic White 
African American 
Asian-American/ Pacific Islander 
 
27 
3 
3 
 
81.8 
9.1 
9.1 
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Table 1:  Baseline Sample Characteristics (n=33) (Con’t) 
Variables N % Mean (SD) 
Highest Level of Education Completed (n=31) 
GED 
High School Diploma 
Some College or Technical School 
College or University Degree 
 
1 
2 
3 
25 
 
3 
6.1 
9.1 
75.8 
 
Type of Primary Cancer (n=33) 
Breast 
Hematologic 
Other solid tumor 
 
17 
7 
9 
 
51.5 
21.2 
27.3 
 
Current Employment Status (n=30) 
Employed for wages full-time 
Employed for wages part-time 
Homemaker 
Self employed 
Retired 
Out of work for more than 1 year 
Disabled 
 
5 
2 
1 
4 
12 
3 
3 
 
15.2 
6.1 
3 
12.1 
36.4 
9.1 
9.2 
 
Health Status in General (n=31) 
Excellent 
Very Good 
Good  
Fair  
 
3 
7 
16 
5 
 
9.1 
21.2 
48.5 
15.2 
 
Participant Smoking History (n=33) 
Never 
Former smoker/current smoker 
 
25 
8 
 
75.8 
24.2 
 
Class and Location (n=33) 
Yoga 
Qigong 
Tai Chi 
 
20 
4 
9 
 
60.6 
12.1 
27.3 
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At baseline participants who were never smokers had a QOL score of 77.41 while 
participants with a smoking history had a QOL score of 75.31(See Table 2 for FACT-G Scores 
by Smoking Status). At 6 months, participants who were never smokers had a QOL score of 
84.41 and participants with a smoking history had a QOL score of 84.06. Most of the participant 
QOL subscale scores increased from baseline to 6 months. QOL (Total FACT-G) increased from 
baseline to 6 months for participants in both smoking groups. In general, never smokers had a 
higher (better) QOL than participants with a smoking history. 
Table 2:  FACT-G Scores by Smoking Status 
Sub-scale* 
(range)  
 
Never (n=22) 
 
Current/Former (n=8) 
 
Never (n=16) 
 
Current/Former (n=8) 
 Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
PWB 
(0-28) 
22.2 (5.30) 19.4 (5.48) 22.1 (5.43) 23.9 (4.67) 
SWB 
(0-28) 
20.3 (5.49) 20.2 (4.18) 21.1 (6.74) 19.6 (4.31) 
EWB 
(0-24) 
17.1 (4.21) 18.4 (3.89) 19.4 (4.92) 17.3 (4.13) 
FWB 
(0-28) 
17.8 (6.67) 18.2 (5.59) 20.3 (6.60) 19.9 (6.08) 
FACT-G 
(0-108) 
77.4 (17.76) 75.3 (15.95) 82.9 (20.98) 80.6 (15.44) 
PWB 
(0-28) 
22.2 (5.30) 19.4 (5.48) 22.1 (5.43) 23.9 (4.67) 
#Higher score indicates a better QOL 
*PWB= Physical scale, SWB= Social/Family scale, EWB= Emotional scale, FWB= Functional 
scale 
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Chapter V: Conclusion and Recommendation 
The purpose of this study was to compare QOL and smoking status among cancer 
survivors who participated in MBME classes (yoga, Tai Chi, Qigong). In general, most QOL 
scores for participants increased from baseline to 6 months after program completion. Overall 
QOL scores improved from baseline to 6 months for all participants.  These findings are 
consistent with Oken et al.’s randomized control trial for seniors who participated in either a 
yoga class, walking exercise class or control group (Oken, Zajdel, Kishiyama, et al. 2006). In 
this trial, participants who participated in the yoga class had a significant improvement in their 
QOL when compared to the walking exercise and control groups.   
Never smokers had a higher or better QOL than participants with a smoking history.  This 
is similar to findings from Sarna et al. (2008). In this study, smokers had the lowest QOL in 
comparison to former and never smokers. Increased numbers of cigarettes per day and fewer 
days since quitting were correlated with decreased QOL (Sarna, Bialous, Cooley, Jun, & 
Feskanich, 2008).  
Limitations 
A limitation of this study included the small number of participants. This study only 
included participants who self-selected to enroll in MBME classes and did not include 
participants who did not have access to classes due to transportation, scheduling/timing/location 
logistics, or were too ill to participate. Also, this study enrolled caregivers who participated in 
the MBME classes, however, there were too few participants (n = 8) to report data.  
Future Recommendations 
Future recommendations would be to include caregivers in the research study and create a 
multicenter project to obtain more data.  These observations reinforce the importance of smoking 
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cessation at every stage in cancer survivorship. Recommendations for future research include 
examining the benefits of MBME with a smoking cessation intervention among cancer survivors 
who smoke. 
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